Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 1 , Pages 28-31 , January 2009

A Case of Unilateral Thalamic Hemorrhagic Infarction as a Result of the Vein of Galen and Straight Sinus Thrombosis

Received 16 April 2008 ,Revised 4 July 2008 ,Accepted 14 July 2008.

References 

  1. Ferro JM, Canhao P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: Results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke. 2004;35:664–670
  2. Bell DA, Wayne LD, Osborn AG, et al. Bithalamic hyperintensity on T2-weighted MR: Vascular causes and evaluation with MR angiography. AJNR Am J Neuroradiol. 1994;15:893–899
  3. Crawford SC, Digre KB, Palmer CA, et al. Thrombosis of the deep venous drainage of the brain in adults. Arch Neurol. 1995;52:1101–1108
  4. Castaigne P, Lhermitte F, Buge A, et al. Para-median thalamic and midbrain infarcts: Clinical and neuro-pathological study. Ann Neurol. 1981;10:127–148
  5. Guberman A, Stuss D. The syndrome of bilateral para-median thalamic infarction. Neurology. 1983;33:540–546
  6. Hermann KA. Thrombosis of the internal cerebral vein associated with transient unilateral thalamic edema: A case report and review of the literature. AJNR Am J Neuroradiol. 2004;25:1351–1355
  7. Forsting M, Krieger D, Seier U, et al. Reversible bilateral thalamic lesions caused by primary internal cerebral vein thrombosis: A case report. J Neurol. 1989;236:484–486
  8. Erbguth F, Brenner P, Schuierer G, et al. Diagnosis and treatment of deep cerebral vein thrombosis. Neurosurg Rev. 1991;14:145–148
  9. Rousseaux M, Cabaret M, Bernati T, et al. Residual deficit of verbal recall after a left internal cerebral vein infarct. Rev Neurol. 1998;154:401–407
  10. Röther J, Weiller C. A case of unilateral deep cerebral venous thrombosis. J Neurol. 1999;246:1096–1097
  11. Haley EC, Brashear HR, Barth JT, et al. Deep cerebral vein thrombosis. Arch Neurol. 1989;46:337–340
  12. Eick JJ, Miller KD, Bell KA, et al. Computed tomography of deep cerebral venous thrombosis in children. Radiology. 1981;140:399–402
  13. Laffite F, Boukobza M, Guichard JP, et al. MRI and MRA for the diagnosis of cerebral venous thrombosis. Clin Radiol. 1997;52:672–679
  14. Dormont D, Anxionnat R, Evrard S, et al. MRI in cerebral venous thrombosis. J Neuroradiol. 1994;21:81–89
  15. Gerszten PC, Welch WC, Spearman MP, et al. Isolated deep cerebral venous thrombosis treated by direct endo-vascular thrombolysis. Surg Neurol. 1997;48:261–266
  16. Smith AG, Cornblath WT, Deveikis P. Local thrombolytic therapy in deep venous thrombosis. Neurology. 1997;48:1613–1619
  17. Brucker AB, Vollert-Rogenhofer H, Wagner M, et al. Heparin treatment in acute cerebral sinus venous thrombosis: A retrospective clinical and MR analysis of 42 cases. Cerebrovasc Dis. 1998;8:331–337
  18. Einhäupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597–600
  19. Kuker W. Unilateral thalamic edema in internal cerebral venous thrombosis: Is it mostly left?. Cerebrovasc Dis. 2001;12:341–345
  20. Valeriano J, Bhagavatula K, Ku A, et al. Isolated straight sinus thrombosis: Clinical and neuroradiologic correlates. J Neuroimaging. 1998;8:106–108
  21. Loevblad KO, Bassetti C, Ozdoba C, et al. Diffusion-weighted MRI suggests the coexistence of cytotoxic and vasogenic edema in a case of deep cerebral venous thrombosis. Neuroradiology. 2000;42:728–731
  22. Kim DI, Yoon PH, Ryu YH, et al. MRI of germinomas arising from the basal ganglia and thalamus. Neuroradiology. 1998;40:507–511
  23. Moon WK, Chang KH, Kim IO, et al. Germinomas of the basal ganglia and thalamus: MR findings and a comparison between MR and CT. AJR Am J Roentgenol. 1994;162:1413–1417
  24. Cheung YK. Central neurocytoma occurring in the thalamus: CT and MRI findings. Australas Radiol. 1996;40:182–184
  25. Uchino M, Kitajima S, Miyazaki C, et al. Bilateral thalamic glioma: Case report. Neurol Med Chir (Tokyo). 2002;42:443–446
  26. Lazzarino LG, Nicolai A, Toppani D. Unilateral cavernous angioma of the thalamus disclosed by transitional disorders in the upward gaze. Minerva Med. 1990;81:731–733
  27. Rapacki TF, Brantley MJ, Furlow TW, et al. Heterogeneity of cerebral cavernous hemangiomas diagnosed by MR imaging. J Comput Assist Tomogr. 1990;14:18–25
  28. Wong GJ, Hung KL, Huang JS, et al. Unilateral thalamic tumor with atrophy of ipsilateral cortical cortex: Report of a case. J Formos Med Assoc. 1991;90:609–611
  29. Kobayashi T, Kageyama N, Kida Y, et al. Unilateral germinoma involving the basal ganglia and thalamus. J Neurosurg. 1981;55:56–62
  30. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance. Radiology. 1992;185:675–686
  31. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: Prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology. 2002;44:656–666
  32. Ciccone A, Canhao P, Falcao F, et al. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Stroke. 2004;35:2428
  33. Hillarp A, Zoller B, Dahlback B. Activated protein C resistance as a basis for venous thrombosis. Am J Med. 1996;101:534–540
  34. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: A clinical perspective. Ann Intern Med. 1997;127:895–903
  35. Dahlback B, Hillarp A, Rosen S, et al. Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis. Ann Hematol. 1996;72:166–176
  36. Rosendaal FR, Koster T, Vandenbroucke JP, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85:1504–1508
  37. Buchanan LTCDS, Brazinsky MAJJH. Dural sinus and cerebral venous thrombosis incidence in young women receiving oral contraceptives. Arch Neurol. 1970;22:440–444
  38. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: Results of international multicenter case-control study. Lancet. 1995;346:1575–1582
  39. Realini JP, Goldzieher JW. Oral contraceptives and cardiovascular disease: A critique of the epidemiologic studies. Am J Obstet Gynecol. 1985;152:729–798
  40. Vandenbroucke JP, Koster T, Briet E, et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet. 1994;344:1453–1457
  41. Rosing J, Tans G, Nicolaes GA, et al. Oral contraceptives and venous thrombosis: Different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Br J Haematol. 1997;97:233–238
  42. Tsai FY, Wang AM, Matovich VB. MR staging of acute dural sinus thrombosis: Correlation with venous pressure measurements and implications for treatment and prognosis. AJNR Am J Neuroradiol. 1995;16:1021–1029

PII: S1052-3057(08)00150-X

doi: 10.1016/j.jstrokecerebrovasdis.2008.07.008

Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 1 , Pages 28-31 , January 2009

Article Tools

* Image Usage & Resolution